---
audienceLevel: patient
cancerTypes:
- prostate
citation: NCI, 2025
language: en
lastReviewed: '2025-12-30'
license: public_domain
reviewFrequency: quarterly
source: NCI
sourceType: 02_nci_core
status: active
tags:
- treatment
title: Enzalutamide - NCI
url: https://www.cancer.gov/about-cancer/treatment/drugs/enzalutamide
version: v1
---

# Enzalutamide - NCI

# Enzalutamide

Placeholder slot

(EN-zuh-LOO-tuh-mide)

This page contains brief information about enzalutamide
and a collection of links to more information about the use of
this drug, research results, and ongoing clinical trials.

US Brand Name(s)

Xtandi

FDA Approved

Yes

[FDA label information for this drug is available at DailyMed.](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b129fdc9-1d8e-425c-a5a9-8a2ed36dfbdf&audience=consumer)

## Use in Cancer

Enzalutamide
is approved
to treat:

- **[Prostate cancer](/Common/PopUps/popDefinition.aspx?id=445079&version=Patient&language=English).** It is used:
- In patients whose cancer is [castrate resistant](/Common/PopUps/popDefinition.aspx?id=753525&version=Patient&language=English) (has not responded to treatments that lower [testosterone](/Common/PopUps/popDefinition.aspx?id=45581&version=Patient&language=English) levels).
- In patients whose cancer has spread to other parts of the body and is [castrate sensitive](/Common/PopUps/popDefinition.aspx?id=804591&version=Patient&language=English) (has responded to treatments that lower testosterone levels).
- In patients whose cancer has not spread to other parts of the body, is castrate sensitive, and is in [biochemical recurrence](/Common/PopUps/popDefinition.aspx?id=543628&version=Patient&language=English) and at high risk of spreading to other parts of the body.

Enzalutamide
is also being studied in the treatment of other types of
cancer.

## More About Enzalutamide

[Definition from the NCI Drug Dictionary](https://www.cancer.gov/publications/dictionaries/cancer-drug/def/560774) - Detailed scientific definition and other names for this drug.

MedlinePlus Information on [Enzalutamide](https://medlineplus.gov/druginfo/meds/a612033.html) - A lay language summary of important information about this drug that may include the following:

- warnings about this drug,
- what this drug is used for and how it is used,
- what you should tell your doctor before using this drug,
- what you should know about this drug before using it,
- other drugs that may interact with this drug, and
- possible side effects.

Drugs are often studied to find out if they can help treat or prevent conditions other than the ones they are approved for. This patient information sheet applies only to approved uses of the drug. However, much of the information may also apply to unapproved uses that are being studied.

## Research Results and Related Resources

[Combination Therapy for Metastatic Prostate Cancer Helps Some Men Live Longer](https://www.cancer.gov/news-events/cancer-currents-blog/2025/xtandi-talzenna-metastatic-prostate-cancer)

[Enzalutamide Gets Added Approval for Prostate Cancer That Hasnâ€™t Spread](https://www.cancer.gov/news-events/cancer-currents-blog/2024/fda-xtandi-prostate-cancer-psa-recurrence)

[FDA Approves New Initial Treatment Option for Some Metastatic Prostate Cancers](https://www.cancer.gov/news-events/cancer-currents-blog/2023/fda-talazoparib-enzalutamide-prostate-cancer)

[Targeted Cancer Therapies](https://www.cancer.gov/about-cancer/treatment/types/targeted-therapies)

[Hormone Therapy for Prostate Cancer](https://www.cancer.gov/types/prostate/prostate-hormone-therapy-fact-sheet)

## Clinical Trials Accepting Patients

[Find Clinical Trials for Enzalutamide](https://www.cancer.gov/research/participate/clinical-trials/intervention/C71744) - Check for trials from NCI's list of cancer clinical trials now accepting patients.
